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A B S T R A C T
Objectives: Recent research indicates that Heart Rate Variability (HRV) is affected in Bipolar Disorders (BD)
patients. To determine whether such alterations are a mere expression of the current mood state or rather
contain longitudinal information on BD course, we examined the potential influence of states adjacent in time
upon HRV features measured in a target mood state.
Methods: Longitudinal evaluation of HRV was obtained in eight BD patients by using a wearable monitoring
system developed within the PSYCHE project. We extracted time-domain, frequency-domain and non-linear
HRV-features and trained a Support Vector Machine (SVM) to classify HRV-features according to mood state.
To evaluate the influence of adjacent mood states, we trained SVM with different HRV-feature sets: 1) belonging
to each mood state considered alone; 2) belonging to each mood state and normalized using information from
the preceding mood state; 3) belonging to each mood state and normalized using information from the
preceding and subsequent mood states; 4) belonging to each mood state and normalized using information from
two randomly chosen states.
Results: SVM classification accuracy within a target state was significantly greater when HRV-features from the
previous and subsequent mood states were considered.
Conclusions: Although preliminary and in need of replications our results suggest for the first time that
psychophysiological states in BD contain information related to the subsequent ones. Such characteristic may be
used to improve clinical management and to develop algorithms to predict clinical course and mood switches in
individual patients.
1. Introduction
In contrast to all the other branches of medicine, psychiatry has
suffered since birth from a lack of external indices to validate the
diagnosis and to monitor the clinical course of disorders. With the
exception of psychiatric conditions caused by a primary somatic
disorder (e.g., Major Depression due to hypothyroidism), no biological
marker to date has proven to be reliable, consistent and accurate
enough to be used in practice for clinical (Antonijevic, 2008; Ozerdema
et al., 2013; Teixeira et al., 2013) as well as forensic purposes (Sartori
et al., 2011). Specifically, while sleep alterations (e.g., REM latency)
(Antonijevic, 2008), hormonal changes (e.g., cortisol rhythm altera-
tions) (Antonijevic, 2008; Teixeira et al., 2013), and brain metabolic
(e.g. metabolism reductions in the prefrontal cortex) (Ozerdema et al.,
2013) or structural alterations (e.g., reductions in hippocampal vo-
lume) (Arnone et al., 2012; McKinnon et al., 2009) have been found to
be altered in mood disorders, none of these changes has shown enough
sensitivity or specificity to make any of them feasible for a clinical use.
Recently, the study of the Autonomic Nervous System (ANS) has
provoked a growing interest in the assessment of both psychiatric as
well as somatic disorders. Significant alterations in heartbeat dy-
namics, including alterations in the Heart Rate Variability (HRV) –
which is the complex modification of the heart rate over time - have
been detected in several somatic and mental disorders (Alvares et al.,
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2016; Henry et al., 2010; Rajendra Acharya et al., 2006). A recent
meta-analysis, for instance, has shown a consistent reduction of
different HRV measures in patients with psychiatric disorders as
compared to controls (Alvares et al., 2016). Such decrease in HRV
was smaller for anxiety disorders and maximal in psychotic patients. It
is important to note that this meta-analysis found such a consistent
reduction by grouping different measures of HRV. As a matter of fact,
HRV analysis does not provide a single index, but a series of features
that describe different and independent information. HRV can be
characterized using distinct methods, which assess it either in time or
in frequency domains (Henry et al., 2010; Rajendra Acharya et al.,
2006). In particular, frequency domain methods consider two compo-
nents of the variability, the low (Low Frequency -LF, 0.04–0.15 Hz)
and the high (High Frequency - HF, 0.15–0.4 Hz) frequencies. The HF
component of the HRV is basically determined by parasympathetic
activity (Rajendra Acharya et al., 2006), while LF is affected by both
parasympathetic and sympathetic modulation. In fact, components
above 0.15 Hz (i.e., HF band) seem to be exclusively mediated by vagal
activity (Henry et al., 2010; Rajendra Acharya et al., 2006), where the
strongest contribution to HF power modulation is due to respiration
(the so-called Respiratory Sinus Arrhythmia). On the other hand,
changes below 0.15 Hz (i.e., LF band) are mediated by both cardiac
vagal and sympathetic nerves with the contribution of other hemody-
namic- and vascular-mediated modulations (Saul et al., 1991), includ-
ing baroreflex activity (Goldstein et al., 2011; Rahman et al., 2011). For
this reason, it has been proposed that the LF/HF ratio may be a valid
index of the sympatho-vagal balance (Montano et al., 2009). However,
given the fact that LF is mediated both by vagal and sympathetic
innervations, and by the previously mentioned other hemodynamic-
and vascular-mediated modulations, both the exact physiological
meaning of LF component and the reliability of the LF/HF ratio as a
measure of sympatho-vagal balance are controversial (Goldstein et al.,
2011; Heathers, 2012; Rahman et al., 2011). In fact, recent reports
suggested that the main SNA component of LF is parasympathetic as
well (McCraty and Shaffer, 2015; Reyes del Paso et al., 2013). Studies
on both physiological (e.g., physical exercise (Warren et al., 1997)) and
pharmacological (e.g. adrenergic agonists (Ahmed et al., 1994))
sympathetic stimulation failed to show the expected LF power in-
creases and, more in general, the published findings are far less
consistent than one can glance at a first sight (Reyes del Paso et al.,
2013).
Another way to assess HRV is by measuring its nonlinear domains,
including complexity and fractal features (Rajendra Acharya et al.,
2006). Analysis methods derived from nonlinear system dynamics have
started a novel approach for studying the characteristics of HRV. These
methods differ from the conventional ones because they are designed to
assess the quality, scaling and correlation properties of the signals
(Aubert et al., 2009). Although nonlinear analyses are more difficult to
interpret in terms of physiological meaning, it has been suggested that
“Nonlinear control of HRV poses potential physiological advantages
in the possibility of adapting quickly and more subtly to changes in
physiological needs” (Aubert et al., 2009). Although some authors
highlighted some shortcomings in the use of this type of features,
including some reproducibility matters (Tan et al., 2009), they have
been suggested to have some valid prognostic and diagnostic uses (e.g.,
(Leistedt et al., 2011; Yang et al., 2013; Yang and Tsai, 2013)).
HRV alterations have been found in cardiac disorders, including
coronary disease and heart failure (Feng et al., 2014; Harris et al.,
2014; Peterson et al., 2014; Radaelli et al., 2014; Sandercock and
Brodie, 2006; Wendt et al., 2014). Particularly, HRV alterations may
predict prognosis and can be used as a marker of the health of the heart
(Sandercock and Brodie, 2006). The most frequent findings are
reduced variability, changes in the HRV spectral distribution and a
reduction in HRV complexity. Thus, in general, a loss of variability or a
prevalence of the LF component of the spectrum are associated with a
more compromised heart function and a poorer prognosis (Sandercock
and Brodie, 2006). On the contrary, an increased HRV is associated
with a better health not only in patients but also in healthy volunteers,
so as to be considered a valuable indicator of general well-being
(Gonçalves et al., 2014). Given this data, it is not surprising that other
studies have shown that HRV can be used as a marker to assess the
severity of distinct clinical conditions, including stroke (Tang et al.,
2015), epilepsy (Lotufo et al., 2012), multi-organ failures (Liu et al.,
2013; Zhang et al., 2015), cancer fatigue (Crosswell et al., 2014) and
autoimmune diseases (Adlan et al., 2014; Holman and Ng, 2008).
Regarding mood disorders, several indications support a link
between heart function and mood: a) There is a frequent occurrence
of comorbidity between mood disorders (particularly, but not only,
Major Depression) and cardiovascular conditions (particularly, but not
only, coronary artery diseases) (Jiang, 2008; Lichtman et al., 2014;
Rovai et al., 2015); b) occurrence of mood disorders in patients with
heart diseases is associated with a worse clinical prognosis (Lichtman
et al., 2014); c) presence of cardiovascular disorders significantly
increases the risk of developing a Mood Disorder (Jiang, 2008); d) a
common biological milieu has been proposed for such a frequent
comorbidity and HRV alterations can be part of it (Rovai et al., 2015).
Thus, it is not surprising to find research on autonomic nervous
system and its alterations in relation to psychopathology. HRV altera-
tions have been found in acute and chronic stressful conditions (Jones
et al., 2014; Parker et al., 2014; Tanev et al., 2014), shift-workers (Lo
et al., 2010), insomnia (Jiang et al., 2015; Maes et al., 2014),
psychosomatic disorders (Salvioli et al., 2015) and major mental
disorders such as schizophrenia, anxiety and mood disorders (Akar
et al., 2014; Clamor et al., 2014; Kemp et al., 2014; Moon et al., 2013;
Sanchez-Gonzalez et al., 2014; Valenza et al., 2013). Particularly, as far
as mood disorders are concerned, changes in the features derived from
HRV analysis were found in Major Depression (Stapelberg et al., 2012;
Wang et al., 2013) and, recently, in Bipolar Disorder patients, who, as a
group, showed a significantly decreased HRV and parasympathetic
activity as compared to healthy individuals (Cohen et al., 2003; Henry
et al., 2010). Finally, a recent study highlighted that the steeper the
reduction of HRV, the more severe was the clinical symptomatology
both in bipolar and schizophrenic patients (Quintana et al., 2015).
On the other hand, modulation of the autonomic nervous system
seems to have relevant effects on the central nervous system both
under physiological, and even more so, pathological conditions. For
instance, vagal nerve stimulation (VNS) has been widely applied in
patients with Major Depression so to become approved by FDA for the
treatment of drug-resistant depression (Berry et al., 2013; Martin and
Martín-Sánchez, 2012). However, results on VNS efficacy remain
inconsistent and largely based on open-labeled studies (Daban et al.,
2008). Another indication of the potential link between autonomic
nervous system and mood is provided by the use of relaxation
techniques based on autonomic nervous system modulation, including
cardio-feedback. These techniques are widely used for managing stress
and negative emotions (Karavidas et al., 2007; Lehrer and Gevirtz,
2014). Nonetheless, the pathophysiological relationship between ANS
and mood is still debated (Thayer and Lane, 2009). Recently, it has
been suggested that the relationship between HRV and mood may be
based on the role of parasympathetic activity, which affects the cardiac
dynamics and plays a role in emotional regulation and flexibility, as
well as in social cognition (Chang et al., 2013; Cristea et al., 2014). For
instance, recent studies have shown an association between HRV and
cerebral blood flow in the middle prefrontal cortex, which is actively
engaged during emotional modulation tasks (Chang et al., 2013;
Thayer et al., 2012). On the basis of these results, the authors claimed
that HRV may be an index of the activity of a central autonomic
network that directly influences both the heart and the control over
behavior (Thayer et al., 2012). Moreover, HRV alterations were
thought to be in a strict relationship with cholinergic mediated
inflammatory modulation and with changes in endocrine and allostatic
systems (Alamili et al., 2015; Kenney and Ganta, 2014). It is interesting
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to note that such alterations also may play a role in the pathophysiology
of mood disorders (Kemp and Quintana, 2013).
Therefore, HRV metrics seem to reflect clinical states in mood
disorders, although they lack specificity, as HRV alterations are shared
among mental disorders and several somatic conditions.
In light of these considerations, within the framework of the
European project PSYCHE (Personalized monitoring SYstems for
Care in mental HEalth), we have developed the PSYCHE platform for
the longitudinal physiological monitoring of Bipolar Disorder patients
through comfortable wearable systems (Javelot et al., 2014). The
PSYCHE system was not primarily conceived to unveil the pathophy-
siology of ANS alterations in mood disorders, but mainly to provide
indices that may be useful for the clinical management of bipolar
patients. The PSYCHE platform consisted of a wearable sensorized t-
shirt, embedded with fabric-based electrodes that acquire ECG, re-
spiration signals, and body activity, as well as a smartphone, collecting
data from the wearable system via Bluetooth technology and that could
be used to record voice parameters and subjective data (e.g., mood and
sleep agendas) (Valenza et al., 2013, 2014b). All the data from each
individual patient, including both the parameters acquired from the
system and the clinical and medication data, were stored in a web-
portal (Javelot et al., 2014).
We previously demonstrated that this system can lead to an
automatic classification of mood states in bipolar disorder patients,
which is highly consistent with the clinical diagnosis (Valenza et al.,
2014a, 2015a, 2013, 2014b). It should be underlined that such a highly
accurate classification was obtained using a multi-feature analysis, that
is, by employing information derived from multiple HRV features to
classify the mood states, and not only from a single one, contrasting
most previous studies (e.g., (Chang et al., 2014; Cohen et al., 2003;
Henry et al., 2010; Latalova et al., 2010)). This aspect is particularly
relevant because the use of multiple features in classification algo-
rithms may help overcoming the above-mentioned specificity issue of
HRV metrics.
Moreover, all the studies published to date measured HRV only
once, and therefore did not provide any longitudinal evaluation. On the
contrary, in our previous studies, we described a potentially useful tool
for the longitudinal clinical management of mood disorder patients.
HRV analysis may provide a very precise estimation of the mood state
of a patient remotely and in the absence of any direct clinical evaluation
(Valenza et al., 2013). Therefore, the PSYCHE system should be
regarded as a clinical decision support tool and not as an alternative
to the clinician assessment. Indeed, HRV monitoring does not replace
the clinical interview (which remains the gold standard for mood
evaluation), but can rather provide an accurate estimation that may
contribute to monitor the patient state in the periods between
specialistic evaluations. This estimation is highly consistent with the
clinical interview, and becomes more accurate when data from previous
mood state evaluations are considered (Valenza et al., 2014a, 2014b).
The above-mentioned observations prompted us to hypothesize
that the current mood state may contain some psychophysiological
features that will be expressed in the following one. If this is the case,
then we expect that mood automatic classification will be improved if
information from subsequent mood states is taken into account.
Specifically, we hypothesized that mood swings occurring during the
clinical course of Bipolar Disorder possess physiological features,
related to cardiovascular dynamics, that depend on the previous mood
state and that contain information related to the subsequent state as
well. In this view, Bipolar Disorder should be regarded in its whole
longitudinal course, considering the symptoms transition in a ‘con-
tinuum’ and not just as a series of states that simply alternate without
any relationship among each other. This is in line also with clinical
observations: for instance, a cycle in which mania follows depression
and precedes euthymia is associated with a longer depressive status
and a lesser intense response to mood stabilizers as compared to a cycle
in which depression follows mania and precedes euthymia
(Koukopoulos et al., 2013).
To test this hypothesis, we conducted a study in a subgroup of
Bipolar Disorder patients to assess whether the HRV-based classifica-
tion of mood states is affected by the clinical course of the illness, that
is, by the mood states that precede and follow a target state. In other
words, the recognition, for instance, of a mixed state through its HRV
feature representation (HRV-fr) at time T would be improved by taking
into account the mood state – that is depression, mixed, mania or
euthymia – at time T-1 and T+1, respectively.
2. Methods
2.1. Patients with BD
We studied long-term HRV dynamics in eight Bipolar Disorder
patients (F/M =3/5; mean age ± s.d. =40 ± 10 years). All the patients
signed a written informed consent document before the enrollment
into the study. The study, conducted under the PSYCHE protocol, was
approved by the local Ethical Committees at the participating institu-
tions, namely, Pisa University Hospital and University of Strasburg. Six
patients had Bipolar I disorder and two had Bipolar II disorder
according to the DSM-IV-TR criteria (APA, 2000). Diagnoses were
performed by board-certified psychiatrists or clinical psychologists.
Patients were recruited at the Pisa University Hospital and at the
Strasbourg University Hospital. All the patients underwent a complete
medical interview during which a physician reviewed their medical
charts to exclude presence or history of any cardiac or somatic disease
that may affect heart dynamics. The two patients recruited in Pisa were
inpatients at the psychiatric ward while the six patients in Strasbourg
were outpatients. All patients were suffering from an active mood
episode at the moment of recruitment and were recorded until
remission was achieved and (for the two inpatients) they were
discharged from the hospital ward (Table 1). Fig. 1 illustrates the
timeline of the study for each patient.
The clinical labeling of the mood states was performed according to
the Young Mania Rating Scale (YMRS) (Young et al., 1978) and the
Quick Inventory of Depressive Symptomatology (QIDS-C) (Rush et al.,
2003) scores. YMRS is an 11 items rating scale to assess maniac
symptoms and it is based on the patient's subjective report of his or her
clinical condition and on clinical observations made during the course
of the psychiatric interview. The QIDS-C is a 16 items scale used to
assess depressive symptoms based on the patient's report.
For our purpose we considered a YMRS score greater than six as
indicating a hypomaniac state; a QIDS-C higher than eight as indicat-
ing a depressive state; mixed state was considered if both the scales
were over the above-mentioned cuts-off. Both YMRS and QIDS-C were
administered by a clinical psychologist or a board-certified psychiatrist
Table 1
Patients demographic and clinical information, including site of recruitment, age, gender,
therapy (drug classes) and clinical evaluation at each acquisition.
Demographics Acquistion
ID gender age treatment 1 2 3 4 5 6
Stras1 M 39 BDZ. MDS. AD. AP HY HY HY ES ES
Stras2 M 51 BDZ. MDS AD. AP HY ES HY HY
Stras3 M 39 MDS, AD. AP HY HY ES ES ES
Stras4 M 33 MDS, AD, AP DP DP DP DP DP ES
Stras5 F 54 MDS, AD, AP DP DP HY DP ES
Stras6 F 37 MDS. AD HY HY ES ES ES
Pisa1 F 32 BDZ. MDS. AD. AP DP DP ES
Pisa2 M 56 MDS. AD MS MS DP DP DP ES
mean 40.5
st.dev 9.7
BDZ: benzodiazepine and/or zolpidem; MDS: mood stabilizers; AP: antipsychotics; AD:
antidepressants; HY: Hypomania; DP: Depression; ES: Eutymic state; MS: mixed state.
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trained for the administrations of the two scales and after reaching an
acceptable inter-rate reliability. The clinical labeling was done the same
day of the HRV evaluation performed with the PSYCHE system.
Because of the observational nature of this study, patients were
taking different combinations of antidepressant, mood stabilizer and/
or antipsychotic drugs (Table 1).
2.2. Data acquisition
We collected 39 ECG recordings (11 hypomaniac, 13 depressive, 2
mixed and 13 euthymic states) (Table 1) with a sampling frequency of
256 Hz. ECG series were processed and analyzed using a self-coded
Matlab software and related toolboxes for digital signal processing (see
Supplementary Materials for further details).
Overall, each patient was followed for a minimum of three and a
maximum of six recording sessions, for a total of more than 300 h of
recordings. The mean ( ± standard deviation) interval between each
recording was 6 ± 2 days. The mean ( ± standard deviation) length of
the recordings was 16 ± 1 h. Table 2 shows the mean ( ± standard
deviation) of the scores of QIDS and YMRS for each state.
2.3. The PSYCHE platform system
To collect psychophysiological data we used the core sensing system
of the PSYCHE project, i.e., the wearable monitoring platform. The
system was developed by Smartex s.r.l. (Pisa, Italy) and consists of a
comfortable sensorized t-shirt with dry textile-based electrodes that
acquire the patient's ECG, a piezo-resistive sensor to acquire the
respiration signal, and a three-axial accelerometer. The system is easy
to use and reaches electrochemical equilibrium between the skin and
electrodes after just a few minutes, allowing for a high and stable
quality of the signal. While using the Psyche system, patients were
instructed to freely perform their usual daily-life activities either at
home or in the hospital ward, while the afore-mentioned physiological
signals were monitored and stored in a microSD card. A smartphone
received through a Bluetooth connection the data from the wearable
system and sent it to a remote server wherein the processing
algorithms were located. Further information on the Psyche project
can be found in (Javelot et al., 2014; Valenza et al., 2013).
2.4. Data analysis
For this study we considered only data extracted from the ECG
signal. Specifically, we considered HRV features defined in a) the time
domain: mean (HRVmean), standard deviation (HRVstd), square root
of the mean of the sum of the squares of differences between adjacent
inter-beats (RMSSD), normalized number of pairs of adjacent inter-
beats differing by more than 50 ms (pNN50); b) the frequency domain:
spectral power in the VLF, LF, HF and their ratio (LF/HF): c) entropic
domains: approximate entropy (ApEn) and sample entropy (SampEn)
and detrended fluctuation indices (DFA-α1, α2) (Valenza et al., 2013,
2014b). The features extraction procedure was performed on contin-
uous, artifact-free, five-minute long recordings of heartbeat dynamics
producing a Heart Rate Variability feature representation (HRV-fr)
‘example’. Parts of the signals with artifacts and artifact-free ECG
signals lasting less than 5 min were discarded and not considered for
further analysis. The length of five minutes was chosen in agreement
with the current guidelines and in order to fulfill the signal processing
requirements of stationarity for long-term HRV series (Rajendra
Acharya et al., 2006; Task Force of the European Society of
Cardiology, 1996). A more detailed description of the algorithms used
for HRV extraction, artifact correction and HRV-features calculation
can be found in the Supplementary Materials.
Each ‘example’ was labeled according to the mood status defined by
the clinical evaluation described above. Every mood state of a given
Bipolar Disorder patient is therefore represented as a set of ‘examples’.
Support vector machines (SVM) algorithms with nonlinear radial basis
kernel were used to test the accuracy of the automatic labeling of the
‘examples’. In order to test whether a relationship was present among
subsequent mood states, we trained and compared results coming from
four SVM algorithms, which take as input four different HRV-fr sets:
1) The HRV-fr set belonging to each mood state was considered alone
and as independent from data coming from other mood states.
2) The HRV-fr set belonging to each mood state was normalized using
the information coming from the previous mood state in time.
3) The HRV-fr set belonging to each mood state was normalized using
the information coming from the previous and subsequent mood
states.
4) The HRV-fr set belonging to each mood state was normalized using
the information coming from two randomly chosen mood states to
control for differences in accuracy exclusively due to a double
normalization.
Details including the mathematical formulation of the normal-
ization procedure are reported in the Supplementary Materials.
Therefore, the first acquisition of each subject provided HRV-fr sets
for procedures 1) and 4); the last acquisition for each subject provided
HRV-fr sets for the procedures 1), 2) and 4) and all the other
acquisitions provided HRV-fr sets for all the described procedures.
Since the subject Pisa1 had only three acquisitions, we could not
compute the HRV-fr set with procedure 4).
The SVM classification algorithms were run for each patient
individually, thus implementing a personalized intra-subject analysis.
Differences in classification accuracy (i.e., the average of sensibility
and specificity) among all the patients, achieved from the four kinds of
HRV-fr set, were tested through the non-parametric Friedman test for
paired data.
3. Results
No physiological artifacts comprising ectopic beats and arrhythmic
events were found in any of the analyzed HRV series. Comparing the
four HRV-fr sets, we found that the normalization using information
from previous and subsequent mood states produced a significantly
higher average classification accuracy as compared to the other
Fig. 1. Schematic time-line of the study. Patients suffering by an active mood episode
were recruited for the study. Patients were studied a minimum of three times and a
maximum of six times. The mean (standard deviation) interval between two contiguous
registrations was 6 ( ± 2) days.
Table 2
Scores for the Young Mania Rating Scale (YMRS) and the Quick Inventory of Depressive
Symptomatology (QIDS-C) for each type of mood state (mean ± st.dev).
QIDS YMRS
Mean St.dev Mean St.dev
mixed state 12.00 3.00 10.50 1.4
hipomaniac state 4.56 2.36 9.18 2.13
depressive state 12.05 3.39 1,00 2.33
euthimic state 2.26 2.08 2,00 2.29
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normalization procedures and to the independent characterization.
Accuracy was (mean ± s.d.) 68.57 ± 8.01 for independent classifica-
tion, 85.26 ± 13.55 for the normalization with the previous mood state,
79.30 ± 7.10 for the normalization with random mood states (not
preceding nor following) and 99.25 ± 1.00 for the normalization with
both previous and subsequent mood states. Friedman test showed a
significant difference for the normalization with previous and subse-
quent mood states as compared to the others (p < 0.001) (Table 3).
Box-plot statistics of all SVM-derived classification accuracies are
shown in Fig. 2.
4. Discussion
We employed a novel integrated system - the PSYCHE platform –
that allows for a longitudinal, non-invasive recording of multiple
physiological parameters to study heartbeat dynamics in BD patients
over time. Our results indicate that the measure of HRV features
accurately reflects the clinical labeling of mood states. Specifically, our
findings show that labeling accuracy increases significantly when
information from previous and subsequent mood states is included
into the analysis. Altogether, our data provides the first experimental
evidence that psychophysiological states in Bipolar Disorder patients
influence each other: the preceding mood state has an influence on the
current one, which, in turn, will influence and contains psychophysio-
logical features of the following one.
Importantly, since data were analyzed at a single subject level, our
results have two main clinical implications. First, the analysis of
longitudinal HRV dynamics is an effective tool to monitor the clinical
state of individual bipolar patients. Thus, the remote monitoring may
provide clinicians with a valuable and reliable measure in the manage-
ment of Bipolar Disorder. This is in line with previous results obtained
by using the PSYCHE platform (Valenza et al., 2015a, 2013).
The second major implication of our results is related to the fact
that the classification of mood states is significantly improved when
considering measures from both the preceding and the subsequent
psychophysiological states. Such an effect indicates that some aspects
of the HRV-fr of the future state (T+1) may be already present in the
target state (T0). If confirmed in larger samples of patients, this finding
may be used to forecast the clinical course of the disorder in individual
patients.
As compared to the previously published studies on HRV and mood
disorders, our approach was multi-parametric, meaning it included
several HRV features at the same time – to train an SVM classification
algorithm – rather than considering only one (or a few). In contrast,
the overwhelming majority of previous studies of this kind focused on
specific alterations of only one, or at most a few, HRV parameters in
patients as a group. Therefore, our results could also to be read within a
wider framework. More specifically, psychiatry and clinical psychology
Table 3
Classification accuracy, expressed in percentage, in the automatical labeling of the patient mood states across the four normalization procedures, using Supported Vector Machine
algorithms. Values are reported as median ± inter-quartile range.
ID Independent characterization Mood depends on the previous
state
Mood depends on a random
state
Mood depends on the previous and
future states
Sens. Spec. Accuracy Sens. Spec. Accuracy Sens. Spec. Accuracy Sens. Spec. Accuracy
Stras1 91.99 19.6 55.79 88,64 70,8 79.72 96,11 51,68 73.89 99,99 98,47 99.23
Stras2 97.03 37.5 67.26 86,46 96,25 91.35 97,84 38,54 68.19 98,96 99,99 99.47
Stras3 88.33 56.02 72.18 88,59 95,18 91.89 87,11 76,77 81.94 100 100 100
Stras4 98.53 16.09 57.31 99,68 91,95 95.81 99,13 65,51 82.32
Stras5 93.04 51.08 70.98 90,58 92,09 91.33 97,15 81,3 89.22 100 100 100
Stras6 68.92 86.02 77.47 10,81 97,13 53.97 73,65 94,62 84.14 94,59 100 97.30
Pisa1 96.34 54.44 75.39 97,47 86,67 92.07
Pisa2 65.86 78.52 72.19 78,08 93,9 85.99 87,26 64,38 75.82 99,32 99,73 99.52
mean 87.51 49.91 68.57 80.04 90.5 85.26 91.83 68.07 79.36 98.81 99.7 99.25
st.dev 12.85 25.07 8.01 28.75 8.6 13.55 9.19 18.77 7.1 2.11 0.61 1,00
Sens.: sensibility; Spec.: specificity.
Fig. 2. Box-plots of inter-patients SVM-derived classification accuracies among different HRV-fr sets. The horizontal (x) axis groups the four HRV-fr sets, whereas the vertical (y) axis
expresses the classification accuracy in percentage. Classification accuracy is defined as the average value between the specificity and sensitivity of the algorithm. Red horizontal lines
indicate the median classification accuracy among all patients. Rectangular plots indicate the variability of the classification accuracy as quantified as inter-quartile range. Post-hoc
analysis performed after a Friedman test showed a significant difference for the latter normalization as compared to the others (p < 0.001).
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have suffered since their dawn from the lack of objective external
indicators to confirm a diagnostic hypothesis or to monitor the clinical
course of mental disorders. For years, an equivalent of what the
glycemic index is for diabetes or what hemoglobin concentration
measure is for anemias, has been searched without success. The
possibility to use a multi-parametric analysis including several features
that provide different information may be a new promising area in the
study of specific markers for mood disorders. In this sense, it is
relevant to underline that we used a multi-feature analysis for our
classification, thus we did not rely on differences in just a single feature.
Single feature analysis has both sensitivity and specificity problems
(Valenza et al., 2013). Similar alterations in single HRV features are
commonly found across several somatic and psychiatric conditions. A
recent meta-analysis has considered different HRV features measured
in psychiatric patients. The meta-analysis showed a consistent reduc-
tion of HRV features in patients as compared to controls (Alvares et al.,
2016). However, the meta-analytic approach pooling the effect size of
each study cannot highlight changes in individual features that may be
specific for a given mental disorder. In turn, multi-feature analysis not
only increases sensitivity but also specificity, as indicated also by the
fact that we were able to classify different mood states with a higher
accuracy.
Moreover, as mental disorders are not homogenous entities, one
index (or the linear combination of a few indices) may not be sufficient
to catch their intrinsic heterogeneity. Our work shows how a machine
learning algorithm (i.e., the SVM algorithm) trained on several features
can be a reliable tool for mood state labeling at a single subject level.
Also, this tool reflects some neurobiological features of Bipolar
Disorders, suggesting the necessity to consider bipolar cycles in their
longitudinal course and not just as a series of distinct episodes of mood
symptoms and states.
In the present study, we focused on the HRV dynamics, which
several studies found altered in mood disorders patients at a group
level. Patients suffering from Major Depression showed a reduction in
HRV parameters, including HF power, when compared to both
euthymic patients and healthy volunteers (Kemp et al., 2010; Liang
et al., 2015; Wang et al., 2013). However, results were not completely
consistent among studies. Kemp and colleagues (Kemp et al., 2014)
found differences in depressed patients with melancholia as compared
to healthy controls in resting-state HRV (including RMSSD, HF), but
these differences were not significant when non-melancholic depressed
patients were considered (Kemp et al., 2014).
Results comparing patients during a depressive episode to remitted
ones are even more controversial. A recent work suggested that HRV
alterations should be considered a trait marker of depression, since
RMSSD and HF were found significantly lower not only in patients
during a depressive episode, but also during remission (Brunoni et al.,
2013). However, some authors claimed that an increase toward HRV
normalization was linked to remission. For instance, successful anti-
depressant treatment with either fluoxetine or doxepine was found to
be associated with HRV increases (Khaykin et al., 1998). Finally, the
cardiac biofeedback seemed both to increase HRV and to reduce
symptoms in patients with primary Major Depression (Karavidas
et al., 2007) and in patients with coronary heart disease experiencing
depressive symptoms (Patron et al., 2012). It is also relevant to
underline that the different studies often examined different HRV
measures. Consequently, a closer look at the results of the individual
studies highlighted some inconsistencies. For instance, Moon and
colleagues (Moon et al., 2013) found differences in HF in depressed
patients as compared to healthy controls, but failed to find differences
in total power and in HF/LF as revealed instead by other studies
(Brunoni et al., 2013; Liang et al., 2015; Wang et al., 2013).
The literature on Bipolar Disorders is even less consistent, while
conversely more limited. Again, typically reduced HRV has been linked
to a manic clinical state (Chang et al., 2014; Cohen et al., 2003; Henry
et al., 2010; Latalova et al., 2010; Moon et al., 2013). Moreover, a
decreased HRV was associated with increased severity in both mood
disorders and in schizophrenia (Chang et al., 2014; Quintana et al.,
2015). As for Major Depression, HRV alterations seem to be a trait
marker for Bipolar Disorder since they were present also during the
euthymic state (Cohen et al., 2003; Latalova et al., 2010), though other
studies failed to identify HRV alterations in euthymic bipolar subjects
as compared to control healthy individuals (Henry et al., 2010; Todder
et al., 2005). Finally, we recently showed that complexity measures of
the HRV may correlate with the clinical status of the patient and can be
used as an objective measure of the course of the disease (Lanata et al.,
2015). However, as in Major Depression, individual studies of Bipolar
Disorders highlighted a reduction of some HRV metrics that differed
from study to study (Chang et al., 2014; Cohen et al., 2003; Henry
et al., 2010; Latalova et al., 2010; Moon et al., 2013). For instance,
recent work showed that un-medicated bipolar patients in maniac
phase exhibited significantly lower HRV mean, HRV variance, LF, and
HF and higher LF/HF compared to controls (Chang et al., 2014). Other
studies partially failed to replicate these differences and found, in
contrast, other significant alterations (Henry et al., 2010; Moon et al.,
2013).
We claim that a part of this inconsistency may be related to the
approach used for data analysis. While most of the studies used one or
a few HRV metrics to characterize their sample and to make compar-
isons at a group level, a single-variable approach is not robust enough
to characterize mood swings and states in Bipolar Disorders when
looking at the individual patient (Valenza et al., 2013). This may also be
related to the neurobiological and psychophysiological heterogeneity of
Mood Disorders. Although a dysfunction of the autonomic central
network has been suggested as a potential correlate of mood disorders
(Kemp and Quintana, 2013), the entity of such an alteration likely may
vary among patients. In a previous pilot work, we defined an effective
pattern of HRV-fr able to discern different pathological mental states in
Bipolar Disorder patients at a single level (Valenza et al., 2013, 2014b).
More recently, we observed that the onset of a new mood state brings
the past clinical history along, and the identification of the next state is
more accurate if the previous one is considered (Valenza et al., 2014b).
Therefore, a better understanding of the patient's mood status can be
achieved considering the dynamics of the disorder rather than the
single observation treated as completely independent.
In the present study, we extended these results by demonstrating
that the classification accuracy significantly increases when HRV-fr
classification takes into account information from previous and sub-
sequent mood states. Thus, while the clinical state may change
completely from a state to the next one, some psychophysiological
fingerprints remain from the previous state. In the same way, some
features may already be changed and be already related to the
subsequent mood state while, at a clinical level, such change is not
yet detectable.
4.1. Study limitations and their relationship with the significance of
the study
The present study highlights several previously unknown charac-
teristics of the cardiovascular dynamics in Bipolar Disorder patients.
Importantly, our results are significant at a single subject level and are
highly consistent across patients, despite individual differences in
clinical features and treatment. However, there are a few limitations
that warrant to consider these findings as preliminary.
The first, and probably the most important one, is the sample size.
Given the high heterogeneity of Bipolar Disorder patients, to sustain a
generalization of our results that fits all the different clinical and
psychophysiological presentations of this disorder could turn out to be
rather speculative. Even if having more patients may be irrelevant in
terms of statistical significance, since we performed a single subject
analysis, it would strengthen our approach by replicating its feasibility
across a wide spectrum of Bipolar Patients.
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Similar considerations can be drawn for treatment. Although the
literature is not completely consistent, several pieces of evidence
indicate that HRV may be affected by medications, specifically, by
antipsychotic and tricyclic drugs (Alvares et al., 2016; Kemp et al.,
2010, 2014; Udupa et al., 2007). The Psyche project was born as an
observational study to evaluate the psychophysiological correlates of
the clinical course of Bipolar Disorder and, therefore, no manipulation
of the treatment prescribed by the patient psychiatrists was allowed.
The validation of the Psyche wearable system for studying longitudinal
dynamics in Bipolar Disorder patients may encourage additional
studies in larger patient samples, including never medicated, first
episode patients who may be assigned to a specific treatment with a
given drug (or class of drugs). This strategy would contribute to
generalize our results and to disentangle the potential effects of
different medications on HRV classification.
Another potential limitation that requires future assessments in
larger samples, is the fact that we cannot completely rule out that
heartbeat dynamics may have been affected also by lifestyles, circadian
rhythms or by the presence of other pathological conditions a part form
those considered as exclusion criteria. The experimental design of our
study, however, was such to minimize any of the above potential
confounds. Specifically, we did not include patients with any somatic
disease, and in particular cardiovascular or neural disorders, which
may affect heartbeat dynamics, as well as HRV features. Moreover, our
experimental setup foresaw long-term (up to 16 h) recordings, from
late afternoon to the next morning. Therefore, most of the recording
sessions covered a period in which the patients slept or were in bed.
This should minimize the effects of different lifestyles and times of the
day on HRV. In addition and more importantly, the analysis was
performed at a single subject level, so that data cannot be affected by
differences in habits and lifestyles, as they presumably remained
constant in each individual subject.
Finally, the use of a multi-parametric approach has a potential
drawback: our analysis did not allow us to identify the contribution of
individual features. Therefore, in the present study, the physiological
meaning remains partially undefined. A deeper understanding of the
HRV alterations that are related to clinical changes in bipolar disorder
would greatly contribute to clarify the pathophysiology of autonomic
nervous system activity in Mood Disorders. For instance, it would be
helpful to evaluate whether HRV alterations in mood disorders are
related to alterations of the emotional modulation process (related to
abnormal activity in the middle prefrontal cortex) or to the cholinergic
mediated alterations of the inflammatory mechanisms (Kemp and
Quintana, 2013). Futhermore, understanding which are the most
relevant features and how they change along with the changing in
mood state would foster the development of algorithms to forecast
clinical course in Bipolar Disorders. As a matter of fact, in another
paper based on data gathered from the PSYCHE project, we began to
explore this issue (Valenza et al., 2016). Briefly, we were able to predict
whether each patient would be in an active state of illness or in
remission at the subsequent observation. We were also able to conclude
that the most informative features for mood state prediction in bipolar
disorder were: the standard deviation of the RR intervals (StdRR);
Square root of the mean squared difference between adjacent R-R
(RMSSD); Poincare SD1 and SD2 and HF power, which are all related
to parasympathetic activity. Therefore, even if the analyses reported in
this study are different than the ones in the Valenza et al. (2016) paper,
our findings suggest that HRV features related to vagal activity are
those that are mainly related to mood changes and mood changes
prediction. However, further studies involving a larger number of
patients are needed to address this issue, by studying the role and
weight of each single HRV metrics. Also, we acknowledge the fact that
during the routine clinical visits, specialists do not have information on
future clinical states and therefore the present results cannot have a
direct impact on clinical practice as it is. Indeed, the presence of future
mood state characteristics in the actual mood state allows us to
speculate that this information may be used to predict the clinical
outcome on the basis of the HRV characteristics. Furthermore, follow-
ing the outcomes of the present study, we developed a decision support
system, which uses information contained in the current mood state to
predict future outcome (preliminary results were described in (Valenza
et al., 2015b)).
4.2. Conclusions
The results of the present study provide for the first time a
psychophysiological evidence, though preliminary and in need of
replication, that mood states should be considered as a longitudinal
sequence, since each HRV-fr in a given state is related to those from the
preceding and subsequent mood states. Importantly, such character-
istics were identified at a single subject level and therefore may be
implemented to monitor the course of mood episodes in Bipolar
Disorder and to develop algorithm that may contribute to predict
clinical course. Our findings provide additional support to the role of
central autonomic network alterations in the pathophysiology of mood
disorders. We believe that a constant monitoring and feedback to both
patients and physicians are not only new keys to managing mental
illness and, ultimately, to identify and forecast critical clinical events,
but also an innovative approach to examine the dysfunction within the
central autonomic network.
Finally, we consider the multi-parametric approach to HRV and,
more in general, to biological signals in course of psychiatric disorders,
a promising approach toward the definition of much-needed objective
parameters in psychopathology.
Acknowledgements
The study was supported by and conducted within the PSYCHE
Project, granted by EU Commission (FP7 ICT-247777 Psyche).
The study was approved by the local ethical committees at the Pisa
University-Hospital (Comitato Etico di Area Vasta Nord Ovest -
Comitato Etico Sperimentazione Farmaco - CESF), Pisa, Italy and at
the Strasbourg University Hospital (Comité de Protection des
Personnes “Est IV”).
Appendix A. Supplementary material
Supplementary data associated with this article can be found in the
online version at doi:10.1016/j.jad.2016.11.008.
References
Adlan, A.M., Lip, G.Y.H., Paton, J.F.R., Kitas, G.D., Fisher, J.P., 2014. Autonomic
function and rheumatoid arthritis-A systematic review. Semin. Arthritis Rheum. 44,
283–304.
Ahmed, M.W., Kadish, A.H., Parker, M.A., Goldberger, J.J., 1994. Effect of physiologic
and pharmacologic adrenergic stimulation on heart rate variability. J. Am. Coll.
Cardiol. 24, 1082–1090.
Akar, S.A., Kara, S., Latifoğlu, F., Bilgiç, V., 2014. Analysis of heart rate variability during
auditory stimulation periods in patients with schizophrenia. J. Clin. Monit. Comput..
Alamili, M., Rosenberg, J., Gögenur, I., 2015. Day-night variation in heart rate variability
changes induced by endotoxaemia in healthy volunteers. Acta Anaesthesiol. Scand.
59, 457–464.
Alvares, G.A., Quintana, D.S., Hickie, I.B., Guastella, A.J., 2016. Autonomic nervous
system dysfunction in psychiatric disorders and the impact of psychotropic
medications: a systematic review and meta-analysis. J. Psychiatry Neurosci. 41,
89–104.
Antonijevic, I., 2008. HPA axis and sleep: identifying subtypes of major depression.
Stress 11, 15–27.
APA, 2000. Diagnostic and statistical manual of mental disorders: dsm-iv-tr. American
Psychiatric Pub., Arlington, VA.
Arnone, D., McIntosh, A.M., Ebmeier, K.P., Munafò, M.R., Anderson, I.M., 2012.
Magnetic resonance imaging studies in unipolar depression: systematic review and
meta-regression analyses. Eur. Neuropsychopharmacol. 22, 1–16.
Aubert, A.E., Vandeput, S., Beckers, F., Liu, J., Verheyden, B., Van Huffel, S., 2009.
Complexity of cardiovascular regulation in small animals. Philos Trans. A Math.
Phys. Eng. Sci. 367, 1239–1250.
C. Gentili et al. Journal of Affective Disorders 209 (2017) 30–38
36
Berry, S.M., Broglio, K., Bunker, M., Jayewardene, A., Olin, B., Rush, A.J., 2013. A
patient-level meta-analysis of studies evaluating vagus nerve stimulation therapy for
treatment-resistant depression. Med. Devices (Auckl.) 6, 17–35.
Brunoni, A.R., Kemp, A.H., Dantas, E.M., Goulart, A.C., Nunes, M.A., Boggio, P.S., Mill,
J.G., Lotufo, P.A., Fregni, F., Benseñor, I.M., 2013. Heart rate variability is a trait
marker of major depressive disorder: evidence from the sertraline vs. electric current
therapy to treat depression clinical study. Int. J. Neuropsychopharmacol. 16,
1937–1949.
Chang, C., Metzger, C.D., Glover, G.H., Duyn, J.H., Heinze, H.-J., Walter, M., 2013.
Association between heart rate variability and fluctuations in resting-state functional
connectivity. Neuroimage 68, 93–104.
Chang, H.-A., Chang, C.-C., Tzeng, N.-S., Kuo, T.B.J., Lu, R.-B., Huang, S.-Y., 2014.
Heart rate variability in unmedicated patients with bipolar disorder in the manic
phase. Psychiatry Clin. Neurosci. 68, 674–682.
Clamor, A., Hartmann, M.M., Köther, U., Otte, C., Moritz, S., Lincoln, T.M., 2014.
Altered autonomic arousal in psychosis: an analysis of vulnerability and specificity.
Schizophr. Res. 154, 73–78.
Cohen, H., Kaplan, Z., Kotler, M., Mittelman, I., Osher, Y., Bersudsky, Y., 2003. Impaired
heart rate variability in euthymic bipolar patients. Bipolar Disord. 5, 138–143.
Cristea, I.A., Valenza, G., Scilingo, E.P., Szentágotai Tătar, A., Gentili, C., David, D., 2014.
Autonomic effects of cognitive reappraisal and acceptance in social anxiety: evidence
for common and distinct pathways for parasympathetic reactivity. J. Anxiety Disord.
28, 795–803.
Crosswell, A.D., Lockwood, K.G., Ganz, P.A., Bower, J.E., 2014. Low heart rate variability
and cancer-related fatigue in breast cancer survivors. Psychoneuroendocrinology 45,
58–66.
Daban, C., Martinez-Aran, A., Cruz, N., Vieta, E., 2008. Safety and efficacy of Vagus nerve
stimulation in treatment-resistant depression. A systematic review. J. Affect. Disord.
110, 1–15.
Feng, J., Wang, A., Gao, C., Zhang, J., Chen, Z., Hou, L., Luo, C., Jiang, Y., Pan, J., 2014.
Altered heart rate variability depends on the characteristics of coronary lesions in
stable angina pectoris. Anadolu Kardiyol. Derg..
Goldstein, D.S., Bentho, O., Park, M.Y., Sharabi, Y., 2011. Low‐frequency power of heart
rate variability is not a measure of cardiac sympathetic tone but may be a measure of
modulation of cardiac autonomic outflows by baroreflexes. Exp. Physiol. 96,
1255–1261.
Gonçalves, T.R., Farinatti, P., Gurgel, J.L., Soares, P.Pd.S., 2014. Correlation between
cardiac autonomic modulation in response to orthostatic stress and indicators of
quality of life, physical capacity, and physical activity in healthy individuals. J.
Strength Cond. Res..
Harris, P.R.E., Stein, P.K., Fung, G.L., Drew, B.J., 2014. Heart rate variability measured
early in patients with evolving acute coronary syndrome and 1-year outcomes of
rehospitalization and mortality. Vasc. Health Risk Manag. 10, 451–464.
Heathers, J.A.J., 2012. Sympathovagal balance from heart rate variability: an obituary.
Exp. Physiol. 97, 556.
Henry, B.L., Minassian, A., Paulus, M.P., Geyer, M.A., Perry, W., 2010. Heart rate
variability in bipolar mania and schizophrenia. J. Psychiatr. Res. 44, 168–176.
Holman, A.J., Ng, E., 2008. Heart rate variability predicts anti-tumor necrosis factor
therapy response for inflammatory arthritis. Auton. Neurosci. 143, 58–67.
Javelot, H., Spadazzi, A., Weiner, L., Garcia, S., Gentili, C., Kosel, M., Bertschy, G., 2014.
Telemonitoring with respect to mood disorders and information and communication
technologies: overview and presentation of the PSYCHE project. BioMed Res. Int.
2014, 104658.
Jiang, W., 2008. Impacts of depression and emotional distress on cardiac disease. Clevel.
Clin. J. Med. 75 (Suppl 2), S20–S25.
Jiang, X.-L., Zhang, Z.-G., Ye, C.-P., Lei, Y., Wu, L., Zhang, Y., Chen, Y.-Y., Xiao, Z.-J.,
2015. Attenuated or absent HRV response to postural change in subjects with
primary insomnia. Physiol. Behav. 140C, 127–131.
Jones, K.I., Amawi, F., Bhalla, A., Peacock, O., Williams, J.P., Lund, J.N., 2014. Assessing
surgeon stress when operating using Heart rate variability and the state trait anxiety
Inventory: will surgery be the death of us? Colorectal Dis..
Karavidas, M.K., Lehrer, P.M., Vaschillo, E., Vaschillo, B., Marin, H., Buyske, S.,
Malinovsky, I., Radvanski, D., Hassett, A., 2007. Preliminary results of an open label
study of heart rate variability biofeedback for the treatment of major depression.
Appl. Psychophysiol. Biofeedback 32, 19–30.
Kemp, A.H., Quintana, D.S., 2013. The relationship between mental and physical health:
insights from the study of heart rate variability. Int. J. Psychophysiol. 89, 288–296.
Kemp, A.H., Quintana, D.S., Gray, M.A., Felmingham, K.L., Brown, K., Gatt, J.M., 2010.
Impact of depression and antidepressant treatment on heart rate variability: a review
and meta-analysis. Biol. Psychiatry 67, 1067–1074.
Kemp, A.H., Quintana, D.S., Quinn, C.R., Hopkinson, P., Harris, A.W.F., 2014. Major
depressive disorder with melancholia displays robust alterations in resting state
heart rate and its variability: implications for future morbidity and mortality. Front.
Psychol. 5, 1387.
Kenney, M.J., Ganta, C.K., 2014. Autonomic nervous system and immune system
interactions. Compr. Physiol. 4, 1177–1200.
Khaykin, Y., Dorian, P., Baker, B., Shapiro, C., Sandor, P., Mironov, D., Irvine, J.,
Newman, D., 1998. Autonomic correlates of antidepressant treatment using heart-
rate variability analysis. Can. J. Psychiatry 43, 183–186.
Koukopoulos, A., Reginaldi, D., Tondo, L., Visioli, C., Baldessarini, R.J., 2013. Course
sequences in bipolar disorder: depressions preceding or following manias or
hypomanias. J. Affect Disord. 151, 105–110.
Lanata, A., Valenza, G., Nardelli, M., Gentili, C., Scilingo, E.P., 2015. Complexity index
from a personalized wearable monitoring system for assessing remission in mental
health. IEEE J. Biomed. Health Inf. 19, 132–139.
Latalova, K., Prasko, J., Diveky, T., Grambal, A., Kamaradova, D., Velartova, H., Salinger,
J., Opavsky, J., 2010. Autonomic nervous system in euthymic patients with bipolar
affective disorder. Neuro Endocrinol. Lett. 31, 829–836.
Lehrer, P.M., Gevirtz, R., 2014. Heart rate variability biofeedback: how and why does it
work. Front. Psychol. 5, 756.
Leistedt, S.J.-J., Linkowski, P., Lanquart, J.-P., Mietus, J.E., Davis, R.B., Goldberger,
A.L., Costa, M.D., 2011. Decreased neuroautonomic complexity in men during an
acute major depressive episode: analysis of heart rate dynamics. Transl. Psychiatry 1,
e27.
Liang, C.-S., Lee, J.-F., Chen, C.-C., Chang, Y.-C., 2015. Reactive heart rate variability in
male patients with first-episode major depressive disorder. Prog.
Neuropsychopharmacol. Biol. Psychiatry 56, 52–57.
Lichtman, J.H., Froelicher, E.S., Blumenthal, J.A., Carney, R.M., Doering, L.V., Frasure-
Smith, N., Freedland, K.E., Jaffe, A.S., Leifheit-Limson, E.C., Sheps, D.S., Vaccarino,
V., Wulsin, L., Epidemiology, A.H.A.S.CotCo, Prevention, Cardiovascular, tCo,
Nursing, S., 2014. Depression as a risk factor for poor prognosis among patients with
acute coronary syndrome: systematic review and recommendations: a scientific
statement from the American Heart Association. Circulation 129, 1350–1369.
Liu, Y.-C., Hung, C.-S., Wu, Y.-W., Lee, Y.-C., Lin, Y.-H., Lin, C., Lo, M.-T., Chan, C.-C.,
Ma, H.-P., Ho, Y.-L., Chen, C.-H., 2013. Influence of non-alcoholic fatty liver disease
on autonomic changes evaluated by the time domain, frequency domain, and
symbolic dynamics of heart rate variability. PLoS One 8, e61803.
Lo, S.-H., Lin, L.-Y., Hwang, J.-S., Chang, Y.-Y., Liau, C.-S., Wang, J.-D., 2010. Working
the night shift causes increased vascular stress and delayed recovery in young
women. Chrono-. Int 27, 1454–1468.
Lotufo, P.A., Valiengo, L., Benseñor, I.M., Brunoni, A.R., 2012. A systematic review and
meta-analysis of heart rate variability in epilepsy and antiepileptic drugs. Epilepsia
53, 272–282.
Maes, J., Verbraecken, J., Willemen, M., De Volder, I., van Gastel, A., Michiels, N.,
Verbeek, I., Vandekerckhove, M., Wuyts, J., Haex, B., Willemen, T., Exadaktylos, V.,
Bulckaert, A., Cluydts, R., 2014. Sleep misperception, EEG characteristics and
Autonomic Nervous System activity in primary insomnia: a retrospective study on
polysomnographic data. Int. J. Psychophysiol. 91, 163–171.
Martin, J.L.R., Martín-Sánchez, E., 2012. Systematic review and meta-analysis of vagus
nerve stimulation in the treatment of depression: variable results based on study
designs. Eur. Psychiatry 27, 147–155.
McCraty, R., Shaffer, F., 2015. Heart Rate Variability: New Perspectives on Physiological
Mechanisms, Assessment of Self-regulatory Capacity, and Health risk. Glob. Adv.
Health Med. 4, 46–61.
McKinnon, M.C., Yucel, K., Nazarov, A., MacQueen, G.M., 2009. A meta-analysis
examining clinical predictors of hippocampal volume in patients with major
depressive disorder. J. Psychiatry Neurosci. 34, 41–54.
Montano, N., Porta, A., Cogliati, C., Costantino, G., Tobaldini, E., Casali, K.R., Iellamo,
F., 2009. Heart rate variability explored in the frequency domain: a tool to
investigate the link between heart and behavior. Neurosci. Biobehav. Rev. 33, 71–80.
Moon, E., Lee, S.-H., Kim, D.-H., Hwang, B., 2013. Comparative Study of Heart Rate
Variability in Patients with Schizophrenia, Bipolar Disorder, Post-traumatic Stress
Disorder, or Major Depressive Disorder. Clin. Psychopharmacol. Neurosci. 11,
137–143.
Ozerdema, A., Güntekind, B., Atagüne, M.I., Başar, E., 2013. Brain oscillations in bipolar
disorder in search of new biomarkers. Suppl. Clin. Neurophysiol. 62, 207–221.
Parker, S.L., Laurie, K.R., Newton, C.J., Jimmieson, N.L., 2014. Regulatory focus
moderates the relationship between task control and physiological and psychological
markers of stress: a work simulation study. Int. J. Psychophysiol. 94, 390–398.
Patron, E., Messerotti Benvenuti, S., Favretto, G., Valfrè, C., Bonfà, C., Gasparotto, R.,
Palomba, D., 2012. Association between depression and heart rate variability in
patients after cardiac surgery: a pilot study. J. Psychosom. Res. 73, 42–46.
Peterson, J.C., Charlson, M.E., Wells, M.T., Altemus, M., 2014. Depression, coronary
artery disease, and physical activity: how much exercise is enough? Clin. Ther. 36,
1518–1530.
Quintana, D.S., Westlye, L.T., Kaufmann, T., Rustan, Ø.G., Brandt, C.L., Haatveit, B.,
Steen, N.E., Andreassen, O.A., 2015. Reduced heart rate variability in schizophrenia
and bipolar disorder compared to healthy controls. Acta Psychiatr. Scand..
Radaelli, A., Mancia, G., Balestri, G., Rovati, A., Anzuini, A., Di Rienzo, M., Paolini, G.,
Castiglioni, P., 2014. Cardiovascular variability is similarly altered in coronary
patients with normal left ventricular function and in heart failure patients. J.
Hypertens. 32, 2261–2266, (discussion 2266).
Rahman, F., Pechnik, S., Gross, D., Sewell, L., Goldstein, D.S., 2011. Low frequency
power of heart rate variability reflects baroreflex function, not cardiac sympathetic
innervation. Clin. Auton. Res. 21, 133–141.
Rajendra Acharya, U., Paul Joseph, K., Kannathal, N., Lim, C.M., Suri, J.S., 2006. Heart
rate variability: a review. Med. Biol. Eng. Comput. 44, 1031–1051.
Reyes del Paso, G.A., Langewitz, W., Mulder, L.J., van Roon, A., Duschek, S., 2013. The
utility of low frequency heart rate variability as an index of sympathetic cardiac tone:
a review with emphasis on a reanalysis of previous studies. Psychophysiology 50,
477–487.
Rovai, D., Giannessi, D., Andreassi, M.G., Gentili, C., Pingitore, A., Glauber, M.,
Gemignani, A., 2015. Mind injuries after cardiac surgery. J. Cardiovasc. Med.
(Hagerstown, Md. ) 16, 844–851.
Rush, A.J., Trivedi, M.H., Ibrahim, H.M., Carmody, T.J., Arnow, B., Klein, D.N.,
Markowitz, J.C., Ninan, P.T., Kornstein, S., Manber, R., Thase, M.E., Kocsis, J.H.,
Keller, M.B., 2003. The 16-Item Quick Inventory of depressive symptomatology
(QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric
evaluation in patients with chronic major depression. Biol. Psychiatry 54, 573–583.
Salvioli, B., Pellegatta, G., Malacarne, M., Pace, F., Malesci, A., Pagani, M., Lucini, D.,
2015. Autonomic nervous system dysregulation in irritable bowel syndrome.
Neurogastroenterol. Motil..
C. Gentili et al. Journal of Affective Disorders 209 (2017) 30–38
37
Sanchez-Gonzalez, M.A., Guzik, P., May, R.W., Koutnik, A.P., Hughes, R., Muniz, S.,
Kabbaj, M., Fincham, F.D., 2014. Trait anxiety mimics age-related cardiovascular
autonomic modulation in young adults. J. Hum. Hypertens..
Sandercock, G.R.H., Brodie, D.A., 2006. The role of heart rate variability in prognosis for
different modes of death in chronic heart failure. Pacing Clin. Electro. 29, 892–904.
Sartori, G., Pellegrini, S., Mechelli, A., 2011. Forensic neurosciences: from basicresearch
to applications and pitfalls. Curr. Opin. Neurol. 24 (4), 371–377.
Saul, J.P., Berger, R.D., Albrecht, P., Stein, S.P., Chen, M.H., Cohen, R.J., 1991. Transfer
function analysis of the circulation: unique insights into cardiovascular regulation.
Am. J. Physiol. 261, H1231–H1245.
Stapelberg, N.J., Hamilton-Craig, I., Neumann, D.L., Shum, D.H., McConnell, H., 2012.
Mind and heart: heart rate variability in major depressive disorder and coronary
heart disease - a review and recommendations. Aust. N. Z. J. Psychiatry 46,
946–957.
Tan, C.O., Cohen, M.A., Eckberg, D.L., Taylor, J.A., 2009. Fractal properties of human
heart period variability: physiological and methodological implications. J. Physiol.
587, 3929–3941.
Tanev, G., Saadi, D.B., Hoppe, K., Sorensen, H.B.D., 2014. Classification of acute stress
using linear and non-linear heart rate variability analysis derived from sternal ECG.
Conf. Proc. IEEE Eng. Med Biol. Soc. 2014, 3386–3389.
Tang, S.-C., Jen, H.-I., Lin, Y.-H., Hung, C.-S., Jou, W.-J., Huang, P.-W., Shieh, J.-S., Ho,
Y.-L., Lai, D.-M., Wu, A.-Y., Jeng, J.-S., Chen, M.-F., 2015. Complexity of heart rate
variability predicts outcome in intensive care unit admitted patients with acute
stroke. J. Neurol. Neurosurg. Psychiatry 86, 95–100.
Task Force of the European Society of Cardiology, aT.FotE.So.C., 1996. Heart rate
variability: standards of measurement, physiological interpretation and clinical use.
task force of the European Society of Cardiology and the North American Society of
pacing and Electrophysiology. Circulation 93, 1043–1065.
Teixeira, A.L., Barbosa, I.G., Machado-Vieira, R., Rizzo, L.B., Wieck, A., Bauer, M.E.,
2013. Novel biomarkers for bipolar disorder. Expert Opin. Med Diagn. 7, 147–159.
Thayer, J.F., Ahs, F., Fredrikson, M., Sollers, J.J., Wager, T.D., 2012. A meta-analysis of
heart rate variability and neuroimaging studies: implications for heart rate variability
as a marker of stress and health. Neurosci. Biobehav. Rev. 36, 747–756.
Thayer, J.F., Lane, R.D., 2009. Claude Bernard and the heart-brain connection: further
elaboration of a model of neurovisceral integration. Neurosci. Biobehav. Rev. 33,
81–88.
Todder, D., Bersudsky, Y., Cohen, H., 2005. Nonlinear analysis of RR interval in
euthymic bipolar disorder. Auton. Neurosci. 117, 127–131.
Udupa, K., Sathyaprabha, T.N., Thirthalli, J., Kishore, K.R., Raju, T.R., Gangadhar, B.N.,
2007. Modulation of cardiac autonomic functions in patients with major depression
treated with repetitive transcranial magnetic stimulation. J. Affect. Disord. 104,
231–236.
Valenza, G., Citi, L., Gentili, C., Lanata, A., Scilingo, E.P., Barbieri, R., 2014a. Point-
process nonlinear autonomic assessment of depressive states in bipolar patients.
Methods Inf. Med. 53, 296–302.
Valenza, G., Citi, L., Gentili, C., Lanata, A., Scilingo, E.P., Barbieri, R., 2015a.
Characterization of depressive States in bipolar patients using wearable textile
technology and instantaneous heart rate variability assessment. IEEE J. Biomed.
Health Inf. 19, 263–274.
Valenza, G., Gentili, C., Lanatà, A., Scilingo, E.P., 2013. Mood recognition in bipolar
patients through the PSYCHE platform: preliminary evaluations and perspectives.
Artif. Intell. Med. 57, 49–58.
Valenza, G., Nardelli, M., Lanata, A., Gentili, C., Bertschy, G., Kosel, M., Scilingo, E.P.,
2016. Predicting mood changes in bipolar disorder Through heartbeat nonlinear
dynamics. IEEE J. Biomed. Health Inform. 20, 1034–1043.
Valenza, G., Nardelli, M., Lanata, A., Gentili, C., Bertschy, G., Paradiso, R., Scilingo, E.P.,
2014b. Wearable monitoring for mood recognition in bipolar disorder based on
history-dependent long-term heart rate variability analysis. IEEE J. Biomed. Health
Inform. 18, 1625–1635.
Valenza, G., Nardelli, M., Lanata, A., Gentili, C., Bertschy, G., Scilingo, E.P., 2015b.
Predicting mood changes in bipolar disorder through heartbeat nonlinear dynamics:
A preliminary study, Computing in Cardiology Conference (CinC), 2015. IEEE, pp.
801–804.
Wang, Y., Zhao, X., O'Neil, A., Turner, A., Liu, X., Berk, M., 2013. Altered cardiac
autonomic nervous function in depression. BMC Psychiatry 13, 187.
Warren, J.H., Jaffe, R.S., Wraa, C.E., Stebbins, C.L., 1997. Effect of autonomic blockade
on power spectrum of heart rate variability during exercise. Am. J. Physiol. 273,
R495–R502.
Wendt, H., Kiyono, K., Abry, P., Hayano, J., Watanabe, E., Yamamoto, Y., 2014.
MultiScale wavelet p-leader based heart rate variability analysis for survival
probability assessment in CHF patients. Conf. Proc. IEEE Eng. Med Biol. Soc. 2014,
2809–2812.
Yang, A.C., Huang, C.-C., Yeh, H.-L., Liu, M.-E., Hong, C.-J., Tu, P.-C., Chen, J.-F.,
Huang, N.E., Peng, C.-K., Lin, C.-P., Tsai, S.-J., 2013. Complexity of spontaneous
BOLD activity in default mode network is correlated with cognitive function in
normal male elderly: a multiscale entropy analysis. Neurobiol. Aging 34, 428–438.
Yang, A.C., Tsai, S.-J., 2013. Is mental illness complex? From behavior to brain. Prog.
Neuropsychopharmacol. Biol. Psychiatry 45, 253–257.
Young, R.C., Biggs, J.T., Ziegler, V.E., Meyer, D.A., 1978. A rating scale for mania:
reliability, validity and sensitivity. Br. J. Psychiatry 133, 429–435.
Zhang, L.-N., Yang, G., Cheng, C., Shen, C., Cui, Y.-Y., Zhang, J., Zhang, J.-J., Shen, Z.-X.,
Zeng, M., Ge, Y.-F., Sun, B., Yu, X.-B., Ouyang, C., Zhang, B., Mao, H.-J., Liu, J.,
Xing, C.-Y., Zha, X.-M., Wang, N.-N., 2015. Plasma FGF23 levels and heart rate
variability in patients with stage 5 CKD. Osteoporos. Int. 26, 395–405.
C. Gentili et al. Journal of Affective Disorders 209 (2017) 30–38
38
